January 20, 2006
People news from 01/20/06 News Brief
Armando Anido, MedImmune’s EVP, sales and marketing, has left the company just weeks after inking a new employment agreement with the Gaithersburg, Md.–based biotech company. A MedImmune spokesperson told the Associated Press that Anido was leaving “to spend more time with his family and pursue other opportunities” but would not provide further details. In December, Anido and several other executives signed new employment agreements with MedImmune’s board. According to that deal, Anido could be eligible for severance based on his salary, which stood at $400,000 in 2005, the AP report said. Anido joined MedImmune in 1999 as SVP, sales and marketing, and was responsible for selling such products as the nasal-spray flu vaccine FluMist and the childhood respiratory drug Synagis. He was promoted to EVP in February 2005.
Pharmix Corporation, a company specializing in drug engineering, announced that Jack Anthony has been named the company's CEO. Prior to joining Pharmix, Anthony, 59, was most recently SVP of business development at Saegis Pharmaceuticals, where he was responsible for its CNS corporate development and licensing activities.
King Pharmaceuticals announced the appointment of Dean Slack to VP, business development and strategy for international and the strategic marketing research department. Slack’s pharmaceutical industry experience spans more than 20 years across Bayer, Johnson & Johnson, Roche and GlaxoSmithKline. Before joining GSK, he worked with Abbott in consumer products and medical devices.
Avanir Pharmaceuticals announced that Randall Kaye has joined the company in the newly created role of VP, medical affairs. Kaye will focus on providing leadership and vision to the medical affairs area and supporting the commercialization of new products from a medical, scientific, regulatory, technical and quality perspective. Immediately prior to joining Avanir, Kaye was VP, medical affairs, for Scios, a division of Johnson & Johnson, where he built and integrated a medical affairs department consisting of 80 professionals.
Genentech has announced six VP appointments: Jennifer Cook to market development; Ashraf Hanna to alliance management and pipeline strategy support; Ann Lee to process development; James Miller to south San Francisco biochemical manufacturing; Quinton Oswald to sales and marketing, tissue growth and repair; and Robert Quinn to CIT business and science applications.
Barr Pharmaceuticals has announced that G. Frederick Wilkinson has agreed to join the company as CEO of Duramed Pharmaceuticals, Barr's proprietary products subsidiary. In this position, Wilkinson will be responsible for managing all aspects of the company's proprietary operations. Wilkinson joins Duramed Pharmaceuticals from Columbia Laboratories, where he served as CEO.
Vion Pharmaceuticals has announced that Meghan Fitzgerald has joined its senior management team as a corporate officer with the title of chief business officer. Fitzgerald will report to Alan Kessman, CEO of the company. Prior to joining Vion, Fitzgerald worked at Pfizer from 2001 to early 2006, where she held positions in strategic planning and marketing.
Interbrand Wood Healthcare, a global brand consultancy, has hired Wes Wilkes as the new managing director, healthcare strategy, in New York. Wilkes brings experience in brand development and management from his time at Pfizer, where he worked on Celebrex, Bextra and the US HIV portfolio. Most recently he was responsible for several of Pfizer’s launch brands, including the anticipated blockbuster Exubera, for which he was responsible for branding and positioning strategies, market conditioning, professional and consumer promotion.
Giant Head, an Internet marketing strategy, communications and eCRM firm, has announced that Gen McGlothlin has been promoted from VP, relationship strategies, to president of Giant Head.
Lanmark Group, a full-service healthcare advertising, marketing and communications agency, recently announced the promotion of C. Ryan Troutman to VP/account supervisor. Previously, Troutman held the position of account supervisor.
Abelson-Taylor has promoted three staff members, respectively, to account supervisor, account executive and assistant account executive. As account supervisor, Shanika Bradley will be responsible for the Europe launch of Tarceva (erlotinib). She will also manage the product’s non–small cell lung cancer indication in the US. Rachel Callahan has been promoted to account executive for the Takeda product Actos (pioglitazone), a diabetes drug. Nicholas Avallone joined Abelson-Taylor in May 2005 as a clinical research associate and has been named assistant account executive for the Genentech brand Rituxan (rituximab), an oncology product.
Conectics, CommonHealth’s research and media planning services unit, has two new hires. Edward Weber has joined as a media planner, where he will be responsible for the implementation and execution of client media schedules and competitive cost analyses while working as a liaison with clients and maintaining relationships with publications. Prior to joining Conectics, Weber was a media planner at Mediaedge:cia. Daena Chadially comes to Conectics as a media coordinator. In this position, she will assist media planners with managing insertion orders and pricing and updating media plans. Previously, Chadially held the position of account coordinator/ad sales manager at Creative Marketing Alliance.
Williams-Labadie promoted Jim Grossmann to SVP, management supervisor. Since joining the agency almost 10 years ago, Grossmann has had primary account responsibility for the agency’s cardiovascular business at Astellas Pharma US (formerly Fujisawa Healthcare). During that time, he has directed a wide range of innovative marketing programs to support the growth of Adenoscan—the largest brand in the Astellas cardiovascular portfolio.
HealthStar Public Relations has announced that Sharon Robustelli has joined the firm as SVP, consumer healthcare. A 15-year PR industry veteran, Robustelli has led key product introductions and Rx to OTC switch programs for some of the industry’s leading organizations, including Procter & Gamble, Johnson & Johnson, Pfizer and Pharmacia & Upjohn. Most recently, Robustelli spent two seasons with the National Basketball Association as senior director, WNBA communications.
Advanstar Communications has appointed Jeffrey Bush as group publisher for its two leading managed care and clinical intelligence platforms: Managed Healthcare Executive and Formulary. Prior to joining Advanstar, Bush was employed by Collapsible Pallet Racks, a leading supplier of commodity plastics.